Having trouble viewing this email? View in your browser.
Symposium, book an appointment, congress summary
EWe hopeyou enjoyed your time at ECCMID 2024
We hope you had a fantastic experience at ECCMID 2024, gaining valuable insights and networking with fellow professionals. As a token of our appreciation for your participation, we invite you to delve deeper into the world of invasive fungal infections.
Sign up for Post-Congress Summary
You may watch our Integrated Symposium at ECCMID 2024 on demand via the ECCMID platform
1For UK healthcare professionals, we have a dedicated promotional portal where you can access additional content and connect with us
For German healthcare professionals, you can also find Germany-specific content and connect with us via our dedicated Germany promotional portal
we invite you to explore MycoAcademy, our educational platform dedicated to invasive fungal disease
Thank you once again for your participation at ECCMID 2024. We look forward to continuing our shared journey towards advancing understanding and treatment in the field of invasive fungal infections.
Best regards,
Mundipharma Team
This email including its attachments/videos/links may contain confidential information. It is sent confidentially to the user of the email address to which it was addressed. If you receive this or you are aware that this is sent to anyone else in error, please immediately delete this email.

Click here for delegate privacy notice.

®: Mundipharma logo is a Registered Trademark of Mundipharma
®: NAPP logo is a Registered Trademark of NAPP Pharmaceuticals
 
Job Code: MSS-AFN-2400009
Date of preparation: April 2024

You have received this email as a contact of ESCMID or one of its affiliated societies.
You can unsubscribe here.